Sponsored by Pri-Med
Pharma
J&J CEO warns against pharmaceutical tariffs
The company expects to lose $400 million this year from already imposed tariffs.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.